Paris (ots/PRNewswire) – – EDITION I demonstrated similar blood sugar control with fewer night-time low blood sugar events compared to Lantus(R)- - Topline results of EDITION II consistent with EDITION I findings – Sanofi announced today that the first phase 3 study results (EDITION I) for its investigational new insulin U300 showed equivalent blood sugar […]